[go: up one dir, main page]

UA99645C2 - Anti-inflammatory and antiallergic gel - Google Patents

Anti-inflammatory and antiallergic gel

Info

Publication number
UA99645C2
UA99645C2 UAA201011783A UAA201011783A UA99645C2 UA 99645 C2 UA99645 C2 UA 99645C2 UA A201011783 A UAA201011783 A UA A201011783A UA A201011783 A UAA201011783 A UA A201011783A UA 99645 C2 UA99645 C2 UA 99645C2
Authority
UA
Ukraine
Prior art keywords
inflammatory
gel
antiallergic
antiallergic gel
dimethyldihydropirimidone
Prior art date
Application number
UAA201011783A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лев Давидович Раснецов
Яков Юделевич Шварцман
Ольга Константиновна Яшнова
Нина Борисовна Мельникова
Александр Александрович Волков
Original Assignee
Лев Давидович Раснецов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лев Давидович Раснецов filed Critical Лев Давидович Раснецов
Publication of UA99645C2 publication Critical patent/UA99645C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine. The inventive anti-inflammatory and antiallergic gel contains N-(β-oxyethyl)-4,6-dimethyldihydropirimidone- a quantity of 3 - 10 wt.% as an active agent, diphenhydramine, or clemastine, or cetiresine in a quantity of 0.005 - 1.0% as an antihistamine preparation, and a gel base which contains carbopol in a quantity of 0.5 - 1.0 wt.% as a thickener, 0.5 - 1.0 wt.% polyethylenoxide 400 - 6000 Da, 0 - 20.0 wt.% glycerin, 0.41 wt.% ethyl alcohol, the rest being filtered water.
UAA201011783A 2008-03-04 2009-03-03 Anti-inflammatory and antiallergic gel UA99645C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008108006/15A RU2370265C1 (en) 2008-03-04 2008-03-04 Gel, possessing anti- inflammatory and antiallergic effect

Publications (1)

Publication Number Publication Date
UA99645C2 true UA99645C2 (en) 2012-09-10

Family

ID=41065445

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201011783A UA99645C2 (en) 2008-03-04 2009-03-03 Anti-inflammatory and antiallergic gel

Country Status (5)

Country Link
EA (1) EA017660B1 (en)
GE (1) GEP20125719B (en)
RU (1) RU2370265C1 (en)
UA (1) UA99645C2 (en)
WO (1) WO2009113910A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019846B1 (en) 2008-10-20 2014-06-30 Юнилевер Нв An antimicrobial composition, comprising thymol and terpineol, and use thereof
CA2801143C (en) 2009-09-24 2017-09-26 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
BR112012029746A2 (en) * 2010-05-31 2016-08-09 Unilever Nv skin treatment composition, method for providing a microbicidal effect to the skin and use of a combination
EP2648681B1 (en) 2010-12-07 2015-01-07 Unilever N.V. An oral care composition
RU2450807C1 (en) * 2011-05-11 2012-05-20 Общество с ограниченной ответственностью фирма "Вита" Stabilised pharmaceutical formulation with antimycotic action
IN2014MN00808A (en) 2011-11-03 2015-09-04 Unilever Plc
RU2543326C2 (en) * 2012-08-21 2015-02-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Pharmaceutical composition for treating skin itching
US8906951B1 (en) 2013-06-24 2014-12-09 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
MX366728B (en) * 2013-06-24 2019-07-22 Menlo Therapeutics Inc Use of nk-1 receptor antagonist serlopitant in pruritus.
US9198898B2 (en) 2013-06-24 2015-12-01 Tigercat Pharma, Inc. Use of NK-1 receptor antagonists in pruritus
RU2614961C1 (en) * 2015-12-31 2017-03-31 Виктория Александровна Чумакова Method for production of pharmaceutical composition with fexofenadine, providing anti-allergic and anti-inflammatory effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129002C1 (en) * 1995-09-08 1999-04-20 Кутузова Ирина Владимировна Composition for treatment of wounds, burns, allergic contact dermatitis
RU2236845C2 (en) * 2002-04-17 2004-09-27 Ставропольское научно-производственное объединение "Пульс" Anti-burning gel and method for its preparing
RU2280438C2 (en) * 2004-01-13 2006-07-27 Государственное Предприятие "Государственный Научный Центр Лекарственных Средств" (Гнцлс) Agent "foridone-gel" for treatment and prophylaxis of cardiovascular diseases
RU2317811C1 (en) * 2006-06-19 2008-02-27 Лев Давидович Раснецов Pharmaceutical composition for treatment of burn (variants) and method for its preparing (variants)

Also Published As

Publication number Publication date
WO2009113910A1 (en) 2009-09-17
EA201001324A1 (en) 2011-02-28
RU2370265C1 (en) 2009-10-20
EA017660B1 (en) 2013-02-28
GEP20125719B (en) 2012-12-25

Similar Documents

Publication Publication Date Title
UA99645C2 (en) Anti-inflammatory and antiallergic gel
AR062000A1 (en) IMMUNE RESPONSE MODIFIER FORMULATIONS
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
WO2007093450A3 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
MY148496A (en) Dpp iv inhibitor formulations
CL2008001114A1 (en) Compounds derived from benzimidazole; pharmaceutical composition; and use in the treatment of diseases such as overactive bladder, pain, obesity, seizures, among others.
PE20140960A1 (en) FORMULATIONS INVOLVING A DPP4 INHIBITOR
AR060019A1 (en) PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
IT1362675B (en) N-HYDROXYAMIDES - SUBSTITUTED WITH TRICYCLIC GROUPS AS INHIBITORS OF THE ISLANDS DEACELITASIS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS
TW200800987A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
MX354416B (en) FORMULATIONS BASED ON NALBUFINE AND ITS USES.
MXPA05010607A (en) Alpha-hydroxy acid ester drug delivery compositions and methods of use.
WO2008136034A3 (en) Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
TW200716204A (en) Pharmaceutical composition
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
WO2008152334A3 (en) Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
SG162766A1 (en) Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
MY142792A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
ATE531703T1 (en) BENZOCHROMEDER DERIVATIVES
MX2009008813A (en) PHARMACEUTICAL COMPOSITION CONTAINING FLOROGLUCINOL AND PARACETAMOL.
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
CY1107277T1 (en) PETROLS
AR055107A1 (en) N- {2 - [((2S) -3 - {[1- (4-CHLOROBENCIL) PIPERIDIN-4-IL] AMINO} -2-HYDROXI-2-METHYLPROPIL) OXI] -4-HYDROXYPHENYL} ACETAMIDE FUROATE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USES TO TREAT AFFECTIONS OR DISEASES WHERE THEY ACT AS MODULATORS OF THE CHEMIOQUINE RECEIVER 1 (CCR1)